These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2019454)

  • 1. Thioredoxin reductase activity at the surface of human primary cutaneous melanomas and their surrounding skin.
    Schallreuter KU; Jänner M; Mensing H; Breitbart EW; Berger J; Wood JM
    Int J Cancer; 1991 Apr; 48(1):15-9. PubMed ID: 2019454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium transport and regulation in human primary and metastatic melanoma.
    Schallreuter KU; Wood JM; Ehrke C; Lemke R
    Biochim Biophys Acta; 1992 Nov; 1160(1):127-33. PubMed ID: 1329982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activity and purification of membrane-associated thioredoxin reductase from human metastatic melanotic melanoma.
    Schallreuter KU; Wood JM
    Biochim Biophys Acta; 1988 Oct; 967(1):103-9. PubMed ID: 2844280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and prognostic significance of Cathepsin L in early cutaneous malignant melanoma.
    Stabuc B; Mrevlje Z; Markovic J; Stabuc-Silih M
    Neoplasma; 2006; 53(3):259-62. PubMed ID: 16652198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stereospecific suicide inhibition of human melanoma thioredoxin reductase by 13-cis-retinoic acid.
    Schallreuter KU; Wood JM
    Biochem Biophys Res Commun; 1989 Apr; 160(2):573-9. PubMed ID: 2719682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Margins of excision for cutaneous melanoma of the eyelid skin: the Collaborative Eyelid Skin Melanoma Group Report.
    Esmaeli B; Youssef A; Naderi A; Ahmadi MA; Meyer DR; McNab A;
    Ophthalmic Plast Reconstr Surg; 2003 Mar; 19(2):96-101. PubMed ID: 12644753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New aspects in the pathophysiology of cutaneous melanoma: a review of the role of thioproteins and the effect of nitrosoureas.
    Schallreuter KU; Wood JM
    Melanoma Res; 1991; 1(3):159-67. PubMed ID: 1841712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of calcium in the regulation of free radical reduction by thioredoxin reductase at the surface of the skin.
    Schallreuter KU; Pittelkow MR; Gleason FK; Wood JM
    J Inorg Biochem; 1986; 28(2-3):227-38. PubMed ID: 2433392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium regulates thioredoxin reductase in human metastatic melanoma.
    Schallreuter KU; Wood JM
    Biochim Biophys Acta; 1989 Aug; 997(3):242-7. PubMed ID: 2765562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased activity of cathepsin B in fibroblasts isolated from primary melanoma in comparison to fibroblasts from normal skin.
    Ulmer A; Körber V; Schmid H; Fierlbeck G
    Exp Dermatol; 1998 Feb; 7(1):14-7. PubMed ID: 9517917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Association Between Excision Margins and Local Recurrence in 11,290 Thin (T1) Primary Cutaneous Melanomas: A Case-Control Study.
    MacKenzie Ross AD; Haydu LE; Quinn MJ; Saw RP; Shannon KF; Spillane AJ; Stretch JR; Scolyer RA; Thompson JF
    Ann Surg Oncol; 2016 Apr; 23(4):1082-9. PubMed ID: 26561405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azelaic acid as a competitive inhibitor of thioredoxin reductase in human melanoma cells.
    Schallreuter KU; Wood JM
    Cancer Lett; 1987 Sep; 36(3):297-305. PubMed ID: 3652030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 and type 2 in stage I malignant melanoma.
    Stabuc B; Markovic J; Bartenjev I; Vrhovec I; Medved U; Kocijancic B
    Oncol Rep; 2003; 10(3):635-9. PubMed ID: 12684636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioredoxin reductase activity in Hermansky-Pudlak syndrome: a method for identification of putative heterozygotes.
    Schallreuter KU; Witkop CJ
    J Invest Dermatol; 1988 Mar; 90(3):372-7. PubMed ID: 3346559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome.
    Garg K; Maurer M; Griss J; Brüggen MC; Wolf IH; Wagner C; Willi N; Mertz KD; Wagner SN
    Hum Pathol; 2016 Aug; 54():157-64. PubMed ID: 27107457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas.
    Haenssle HA; Mograby N; Ngassa A; Buhl T; Emmert S; Schön MP; Rosenberger A; Bertsch HP
    JAMA Dermatol; 2016 Mar; 152(3):291-8. PubMed ID: 26536613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free radical reduction by thioredoxin reductase at the surface of normal and vitiliginous human keratinocytes.
    Schallreuter KU; Pittelkow MR; Wood JM
    J Invest Dermatol; 1986 Dec; 87(6):728-32. PubMed ID: 2431070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of dicarbonyl/L-xylulose reductase (DCXR) in human skin and melanocytic lesions: morphological studies supporting cell adhesion function of DCXR.
    Cho-Vega JH; Vega F; Schwartz MR; Prieto VG
    J Cutan Pathol; 2007 Jul; 34(7):535-42. PubMed ID: 17576332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Value of High-frequency 20 MHz Ultrasonography for Preoperative Measurement of Cutaneous Melanoma Thickness.
    Kozárová A; Kozár M; Tonhajzerová I; Pappová T; Minariková E
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):15-20. PubMed ID: 29782294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanoma.
    Whiteman DC; Zhou XP; Cummings MC; Pavey S; Hayward NK; Eng C
    Int J Cancer; 2002 May; 99(1):63-7. PubMed ID: 11948493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.